National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

Lars Ehlers; Wilhelmina Maria Müskens; Lotte Groth Jensen; Mette Kjølby; Grethe Andersen

The purpose of this analysis was to assess the budgetary impact and cost effectiveness of the national use of thrombolysis with alteplase (recombinant tissue plasminogen activator; rt-PA) for acute ischaemic stroke via telemedicine in Denmark.

Link til ekstern hjemmeside

Udgivelsesform Videnskabelige artikler
År 2008
Udgiver CNS Drugs 2008;22(1):73-81.